Literature DB >> 2451673

Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the alpha subunit.

T Barkas1, J M Gabriel, A Mauron, G J Hughes, B Roth, C Alliod, S J Tzartos, M Ballivet.   

Abstract

Monoclonal antibodies (mAbs) to the main immunogenic region (MIR) bind to fusion proteins containing region 37-200 of the alpha chain of Torpedo, mouse, and chicken nicotinic acetylcholine receptor. In the case of the mouse alpha chain, these mAbs react with sequence 61-216 but not with 74-216. A synthetic peptide M1, containing residues 61-76 of the mouse alpha chain, also binds these anti-MIR mAbs, showing that all or part of their binding site is included in this region. The conformational dependence and epitope specificity of the mAbs are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451673

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.

Authors:  N Venkatesh; S H Im; M Balass; S Fuchs; E Katchalski-Katzir
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Inhibition mechanism of the acetylcholine receptor by alpha-neurotoxins as revealed by normal-mode dynamics.

Authors:  Abraham O Samson; Michael Levitt
Journal:  Biochemistry       Date:  2008-03-08       Impact factor: 3.162

Review 3.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 4.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

5.  Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.

Authors:  A Melms; S Chrestel; B C Schalke; H Wekerle; A Mauron; M Ballivet; T Barkas
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

6.  A Computational Analysis of the Factors Governing the Dynamics of α7 nAChR and Its Homologs.

Authors:  Alican Gulsevin; Jens Meiler; Nicole A Horenstein
Journal:  Biophys J       Date:  2020-09-16       Impact factor: 4.033

7.  Antigenic role of single residues within the main immunogenic region of the nicotinic acetylcholine receptor.

Authors:  I Papadouli; S Potamianos; I Hadjidakis; E Bairaktari; V Tsikaris; C Sakarellos; M T Cung; M Marraud; S J Tzartos
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

8.  An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis.

Authors:  A M Salmon; C Bruand; A Cardona; J P Changeux; S Berrih-Aknin
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

9.  Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction.

Authors:  T Guyon; P Levasseur; F Truffault; C Cottin; C Gaud; S Berrih-Aknin
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss.

Authors:  T Guyon; A Wakkach; S Poea; V Mouly; I Klingel-Schmitt; P Levasseur; D Beeson; O Asher; S Tzartos; S Berrih-Aknin
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.